Company profile: Almac
1.1 - Company Overview
Company description
- Provider of contract development and manufacturing services to pharmaceutical and biotech companies globally, including R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply, and IXRS technology. Offers genomic services, clinical trial assays, companion diagnostics, PD biomarker testing, CDx manufacturing, and the claraT software.
Products and services
- Companion Diagnostics: Delivers commercial-scale development, manufacture, and commercialisation of companion diagnostics, establishing CDx development and commercialisation models
- CDx Manufacturing: Produces IVD-focused manufacturing of lab developed tests and IVD kits, encompassing packaging, design, quality control, and logistics
- Genomic Services: Supplies multi-platform genomics capabilities with diverse chemistry options, delivering data sciences support and sample management service
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Almac
PharmaSeek
HQ: United States
Website
- Description: Provider of consulting and training solutions for clinical research sites, helping institutions, investigators, and independent sites decrease study start-up timelines by assuming administrative burdens of research management, including study identification, contract and budget negotiation, coverage analysis, and financial management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaSeek company profile →
Alliance Pharma
HQ: United Kingdom
Website
- Description: Provider of healthcare solutions through the acquisition and licensing of mature pharmaceutical products, with manufacturing, storage, logistics, and sales operations controlled by Alliance and outsourced to leading specialist organisations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alliance Pharma company profile →
Hydra Biosciences
HQ: United States
Website
- Description: Provider of biopharmaceutical drug discovery and development leveraging novel ion channels to develop drugs for pain, inflammation, cardiovascular and other diseases, based in Cambridge, Massachusetts, utilizing proprietary high-throughput screening platforms.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hydra Biosciences company profile →
Clinilabs
HQ: United States
Website
- Description: Provider of clinical drug development services specializing in CNS medications, from first-in-human to Phase 3 trials. Offers global site selection via a network in 42 countries, decentralized trials using telemedicine, electronic tools, remote assessment and wearables, corelab data services to centralize and improve data accuracy, and centralized PSG and EEG capture and analysis for clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinilabs company profile →
Triangle Insights Group
HQ: United States
Website
- Description: Provider of strategy consulting services to life sciences organizations, guiding leaders on critical business issues with deep industry knowledge. Offerings include pricing and market access, commercial strategy and execution, R&D prioritization, commercial launch strategy, due diligence, and portfolio strategy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Triangle Insights Group company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Almac
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Almac
2.2 - Growth funds investing in similar companies to Almac
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Almac
4.2 - Public trading comparable groups for Almac
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →